Summary
Serum levels of acetoacetate, 3-hydroxybutyrate and the 3-hydroxybutyrate/acetoacetate ratio were determined in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients by a new sensitive method. Efforts were made to differentiate Type 1 and Type 2 diabetes by serum levels of ketone bodies and to determine whether their measurement is a useful way of monitoring diabetic control. In Type 2 diabetes, serum levels of total ketone bodies did not exceed 2.0 mmol/l even if the patients were untreated or poorly controlled. In Type 1 diabetic subjects, treated with once or twice daily injections of insulin, morning serum levels of acetoacetate, 3-hydroxybutyrate and total ketone bodies were significantly elevated by four-, ten- and sevenfold, respectively. In Type 2 diabetic subjects treated with diet or sulphonylureas, serum levels of 3-hydroxybutyrate were highest before breakfast, next highest before dinner and decreased after each meal. The changes were roughly inversely proportional to serum insulin levels. In addition, insulin treatment normalized fasting serum levels of ketone bodies better than diet or sulphonylurea treatment. Acetoacetate was also significantly increased in both types of diabetes to a lesser extent, but no apparent diurnal rhythm was observed. Determination of serum levels of ketone bodies is useful for the diagnosis of Type 1 diabetes (those with total ketone bodies > 2 mmol/l) and for detecting insufficient insulin therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
WHO Expert Committee on Diabetes Mellitus (1980). Second report, Technical Report Series 646, Geneva
Keisberg RA (1978) Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Int Med 88:681–695
Werk Jr EE, Knowles HC (1960) The blood ketone and plasma free fatty acids concentration in diabetic and normal subjects. Diabetes 10: 22–32
MacGillivray MH, Li PK, Lee JT, Mills BJ, Voorhess ML, Putman TI, Schaefer PA (1981) Elevated plasma β-hydroxybutyrate concentrations without ketonuria in healthy insulin-dependent diabetic patients. J Clin Endocrinol Metab 52: 982–987
Harano Y, Kosugi K, Hyosu T, Uno S, Ichikawa Y, Shigeta Y (1983) Sensitive and simplified method for the differential determination of serum levels of ketone bodies. Clinica Chim Acta 134: 327–337
Salway JG (1969) The simultaneous determination of acetoacetate and glucose in capillary blood. Clin Chim Acta 25: 109–116
Hoffman WS (1973) A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem 120: 51–55
Yalow RS, Glick SM, Roth J, Berson SA (1965) Plasma insulin and growth hormone levels in obesity and diabetes. Ann NY Acad Sci 131:357–373
Imagawa K, Nishino T, Shin T, Uegata S, Eyanaihara C, Yanaihara N (1979) Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon. Endocrinol Japon 26: 123–132
Harano T, Ohgaku S, Kosugi K, Yasuda H, Nakano T, Kobayashi M, Hidaka H, Izumi K, Kashiwagi A, Shigeta Y (1893) Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion. J Clin Endocrinol Metab 52: 982–987
Trivelli LA, Ranney HM, Lai HT (1971) Hemoglolin components in patients with diabetes mellitus. New Engl J Med 284: 353–357
Kuzuya T, Mastuda A, Sakamoto Y (1978) C-peptide immunoreactivity in urine. Diabetes 27 (Suppl 1): 210–215
Sterkey EB (1943) P-dinitrobenzene. Organic Synthesis. Coll 2: 225–228
Harano Y, Kojima H, Suzuki M, Kashiwagi A, Hyosu T, Hidaka H, Hoshi M, Izumi K, Shigata Y (1984) Serum levels of ketone bodies as metabolic markers monitoring diabetic control in Type 1 diabetic subjects. Med J Osaka Univ (in press)
Wildenhoff KE (1972) Diurnal variations in the concentrations of blood acetoacetate, 3-hydroxybutyrate and glucose in normal persons. Acta Med Scand 191: 303–306
Wildenhoff KE, Hohansen JP, Karstoft H, Yde H, Sorensen S (1974) Diurnal variations in the concentrations of blood acetoacetate and 3-hydroxybutyrate. Acta Med Scand 195: 25–2818
MacGillivray MH, Voorhess ML, Putnam TI, Li PK, Schaefer PA, Bruck E (1982) Hormone and metabolic profiles in children and adolescent with Type I diabetes mellitus. Diabetes Care 5 (Suppl 1) 38–47
Harano Y, Hidaka H, Suzuki M, Kojima H, Shigeta Y (1984) Importance of determining serum levels of 3-hydroxybutyrate as a metabolic marker of insulinopenia. In: Sakamoto N (ed) Second Japan-Korea symposium on diabetes mellitus. Excerpta Medica, Amsterdam (in press)
Dahlquist G, Blom L, Bolme P, Hagenfeldt L, Linggren F, Dersson B, Thalme B, Theorell M, Westin S (1982) Metabolic control in 131 juvenile-onset diabetic patients as measured by HBA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care 5: 399–403
Harano Y, Kosugi K, Kashiwagi A, Akano T, Hidaka H, Shigeta Y (1982) Regulatory mechanism of ketogenesis by glucagon and insulin in isolated and cultured hepatocytes. J Biochem (Tokyo) 91: 1739–1748
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harano, Y., Kosugi, K., Hyosu, T. et al. Ketone bodies as markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control. Diabetologia 26, 343–348 (1984). https://doi.org/10.1007/BF00266034
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00266034